相关实验视频

Updated: Jun 13, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

设计EVs-Mediated miR-222 针对PTEN/FN1轴逆转了HER2-阴性乳腺癌中人类循环素抵抗

Sujin Yang^1,2, Mei Yang³, Quanfeng Shao³

¹Department of Breast Surgery, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China.

|June 12, 2025

概括

携带miR-222抑制剂的工程外细胞囊泡可以通过向miR-222/PTEN/FN1通路来克服乳腺癌中的反环素耐药性,从而提供一种新的治疗方法.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物技术是生物技术.

背景情况:

反环素耐药性是乳腺癌治疗的主要障碍,由瘤免疫微环境变化和细胞耐药性驱动.
了解化学阻力背后的分子机制对于开发有效的治疗策略至关重要.

研究的目的:

研究微RNA-222 (miR-222) 在乳腺癌中抗逆环素的作用.
探索工程外细胞囊泡 (EVs) 作为克服药物耐药性的输送系统的潜力.

主要方法:

对乳腺癌患者的转录组分析,以确定瘤透细胞亚型.
不同表达分析和Tandem质标记 (TMT) 质谱测量以确定关键的分子标 (miR-222,PTEN,FN1).
开发工程 EVs,以提供 miR-222 抑制剂.
分子对接以分析蛋白质相互作用.
在体内异种移植模型来评估治疗疗效.

主要成果:

D亚型的乳腺瘤显示M1巨细胞透和更好的结果.
miR-222在抗胺素的细胞上调,准PTEN和调节FN1.1.
提供miR-222抑制剂的工程 EVs通过抑制miR-222和恢复PTEN逆转了体外和体内氨酸耐药性.
通过分子对接确定了特定的PTEN-FN1相互作用.
患者的循环EV显示出与治疗反应一致的分子变化.

结论:

建立了涉及微RNA-222/PTEN/FN1轴的EVs介导耐药性的新机制.
工程电动汽车是克服乳腺癌中抗胰岛素耐药性的有希望的治疗策略.
循环电动汽车有可能成为监测治疗反应的生物标志物.

关键词:

乳腺癌乳腺癌乳腺癌化学电阻是一种化学电阻.细胞外囊泡中的细胞外囊泡.微型RNAs (miRNAs) 是一种微型RNA.瘤免疫微环境是一个微环境.

更多相关视频

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...